Predictors of decline in walking ability in community-dwelling Alzheimer's disease patients: Results from the 4-years prospective REAL.FR study

Abstract : Introduction
The aim of this study was to explore the predictors of decline in walking ability in patients with Alzheimer's disease (AD).
Methods
The prospective REseau surla maladie ALzheimer FRançais (REAL.FR) study enrolled six hundred eighty four community-dwelling AD subjects (71.20% women; mean age 77.84 Standard Deviation, SD, 6.82 years, Mini-Mental State Examination 20.02, SD 4.23). Decline in walking ability was defined as the first loss of 0.5 points or more in the walking ability item of the Activities of Daily Living scale (ADL), where higher score means greater independence, during the four-years of follow-up. Demographic characteristics, co-morbidities, and level of education were reported at baseline. Disability, caregiver burden, cognitive and nutritional status, body mass index, balance, behavioral and psychological symptoms of dementia, medication, hospitalization, institutionalization and death were reported every six months during the four years. Cox survival analyses were performed to assess the independent factors associated with decline in walking ability.
Results
The mean incident decline in walking ability was 12.76% per year (95% Confidence Interval (CI) 10.86 to 14.66). After adjustment for confounders, the risk of decline in walking ability was independently associated with older age (Relative Risk, RR = 1.05 (95% CI 1.02 to 1.08)), time from diagnosis of dementia (RR = 1.16 (1.01 to 1.33)), painful osteoarthritis (RR = 1.84 (1.19 to 2.85)), hospitalization for fracture of the lower limb (RR = 6.35 (3.02 to 13.37)), higher baseline ADL score (RR = 0.49 (0.43 to 0.56)), and the use of acetylcholinesterase inhibitors (RR = 0.52 (0.28 to 0.96)).
Conclusions
The risk of decline in walking ability is predicted by older age, increased dementia severity, poor functional score, and orthopedic factors and seems to be prevented by the use of acetylcholinesterase inhibitors medication.
Type de document :
Article dans une revue
Alzheimer's Research and Therapy, BioMed Central, 2013, 5 (5), pp.52
Liste complète des métadonnées

Littérature citée [44 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00924505
Contributeur : Ed. Bmc <>
Soumis le : lundi 6 janvier 2014 - 21:08:47
Dernière modification le : lundi 17 novembre 2014 - 14:42:10
Document(s) archivé(s) le : jeudi 10 avril 2014 - 17:45:56

Fichiers

alzrt216.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

  • HAL Id : inserm-00924505, version 1

Collections

Citation

Yves Rolland, Christelle Cantet, Philipe De Barreto, Matteo Cesari, Gabor Van Kan, et al.. Predictors of decline in walking ability in community-dwelling Alzheimer's disease patients: Results from the 4-years prospective REAL.FR study. Alzheimer's Research and Therapy, BioMed Central, 2013, 5 (5), pp.52. 〈inserm-00924505〉

Partager

Métriques

Consultations de la notice

160

Téléchargements de fichiers

95